Clinical Trial Update: Safety, Efficacy and Pharmacokinetics of an Oral Iron Chelator Given for a Year to Pediatric Patients With Iron Overload [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety, efficacy, and pharmacokinetics of an oral iron chelator administered for one year in pediatric patients with transfusional iron …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia
• Transfusional Iron Overload

Drugs mentioned

• oral iron chelator

Snippet

Sponsor: Shire | Conditions: Transfusional Iron Overload, Beta-Thalassemia | Phase 2 | Status: TERMINATED | Results posted: 2015-05-27